NeuroPace Inc (NPCE) USD0.001

Sell:$13.25Buy:$14.45$0.29 (2.13%)

Prices delayed by at least 15 minutes
Sell:$13.25
Buy:$14.45
Change:$0.29 (2.13%)
Prices delayed by at least 15 minutes
Sell:$13.25
Buy:$14.45
Change:$0.29 (2.13%)
Prices delayed by at least 15 minutes

Company Information

About this company

NeuroPace, Inc. is a medical device company. The Company is focused on transforming the lives of people living with epilepsy by reducing or eliminating the occurrence of debilitating seizures. Its novel and differentiated RNS System is a brain-responsive platform that delivers personalized, real-time treatment at the seizure source. The Company has developed its RNS System to address the individualized nature of drug-resistant epilepsy and deliver a safe therapy for focal onset seizures anywhere in the brain. The RNS System is a device that records brain activity data and allows clinicians to monitor patients not only in person, but also remotely. RNS System monitors and analyzes the brain’s electrical activity, recognizes patient-specific abnormal patterns, and delivers treatment at the seizure source. The Company’s RNS System is also engaged in treating other brain disorders, including depression, impulse control disorders, memory disorders, and post-traumatic stress disorder.

Key people

Joel D. Becker
President, Chief Executive Officer, Director
Rebecca L. Kuhn
Chief Financial Officer, Vice President of Finance and Administration, Corporate Secretary
Katie Keller
Vice President - Marketing
Amy Treadwell
Vice President - Human Resources
Brett Wingeier
Vice President - Research and Development
Martha J. Morrell
Chief Medical Officer
Frank M. Fischer
Independent Chairman of the Board
Scott Huennekens
Director
Lisa Andrade
Independent Director
Uri Geiger
Independent Director
Rakhi Kumar
Independent Director
Click to see more

Key facts

  • EPIC
    -
  • Location
    United States
  • Sector
    Healthcare
  • Industry
    Medical Equipment & Supplies
  • ISIN
    US6412881053
  • Market cap
    $410.71m
  • Employees
    171
  • Shares in issue
    29.85m
  • Exchange
    NASDAQ
  • Index

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.